Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |